TAVR Post-dilation Is Safe

Courtesy of Dr. Carlos Fava.

Numerous studies have shown that the presence of aortic regurgitation after TAVR is associated with worse evolution, and that balloon post-dilation (BPD) is the adequate strategy to correct this. However, a few reports using first generation valves have associated BPD to complications such as stroke, annulus rupture and valve displacement, (among others).

Diálisis post TAVI, una complicación grave que se hace menos frecuenteThe study looked at 1616 patients from the PARTNER 2 and SAPIENS 3 trials; 208 of these patients received BPD (12.5%).

 

Baseline characteristics were similar, except patients receiving BPD had higher STS score (7.2 vs. 6.4 p=0.0008), less lung capacity, a history of immunosuppression, atrial fibrillation and more eccentric annular valve. In addition, there was less oversizing and more subvalvular calcification, though with no difference in annulus calcification.


Read also: Debris Captured by SENTINEL Devices Result Different across Different Valves.


After TAVR, BPD favored a larger aortic valve area (1.72± 0.41 cm2 vs. 1.66±0.37 cm2; p = 0.04). There was no mismatch or transvalvular aortic regurgitation, but there was more paravalvular regurgitation.

At 30 day follow-up, there were no differences in death or stroke.

 

At one year, there were no differences in mortality, cardiac mortality, stroke or rehospitalization, but there was higher presence of minor stroke, and percutaneous valve reintervention.


Read also: High-Sensitivity Troponins Turned All Events into Infarctions; the 4th Universal Definition Clarifies Things.


Predictors of BPD need were the use of immunosuppressors, moderate to severe sub-annular calcification, and oversizing, given the valve’s elliptical quality.

 

Conclusion

BPD is more frequently used in patients with low oversizing and severe calcification. BPD was not associated with procedural complications or an increase of fatal major events and rehospitalization at one year follow up.

 

Comment

This analysis of two large studies show us that BPD is feasible and safe and that it improves evolution, since it reduces the presence of severe leak.

 

It is important to properly assess calcium burden and oversizing in trying to reduce paravalvular leak and the need of BPD.

 

Though there were no more major strokes, there was a high rate of minor stroke and most likely more micro embolisms in patients undergoing BPD. Cerebral protection devices might be useful in this sense.

 

Courtesy of Dr. Carlos Fava.

 

Original title: The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.

Reference: Rebecca T. Hahn, et al. J Am Coll Cardiol Intv 2018;11:1710–8


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...